Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FQ61F
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,782
Award facts
- Contract value 100% obligated
- $12,782.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,782.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The order, issued on May 22, 2025, with an ultimate completion date of June 13, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Alecensa (alectinib) is a targeted cancer therapy used primarily in oncology treatment protocols, and this procurement supports the Department of Defense's pharmaceutical supply requirements for military health system operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract awards from DLA, demonstrating capability in distributing branded and generic prescription drugs, biologics, and specialized medical products to government healthcare facilities. The company's woman-owned small business status and registered SAM.gov credentials since 2001 position it as a qualified vendor for federal pharmaceutical procurement within the Defense Logistics Agency's broader medical supply distribution network.
Quick answers
Who was awarded contract SPE2DB25FQ61F?
SPE2DB25FQ61F was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 22, 2025.
How much is contract SPE2DB25FQ61F worth?
The government has obligated $12,782 on SPE2DB25FQ61F.
Is contract SPE2DB25FQ61F an order under another contract?
Yes. SPE2DB25FQ61F is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ61F competed?
The extent of competition for SPE2DB25FQ61F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award